Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;26(6):392-402.
doi: 10.1097/MOO.0000000000000486.

Laryngopharyngeal Reflux Disease: Clinical Presentation, Diagnosis and Therapeutic Challenges in 2018

Affiliations
Review

Laryngopharyngeal Reflux Disease: Clinical Presentation, Diagnosis and Therapeutic Challenges in 2018

Jerome R Lechien et al. Curr Opin Otolaryngol Head Neck Surg. .

Abstract

Purpose of review: To review the recent literature on presentation, diagnosis and treatment of laryngopharyngeal reflux.

Recent findings: Patients with laryngopharyngeal reflux have a higher risk for gastroesophageal reflux and respiratory-related diseases. Many symptoms and findings are underestimated, contributing to the inconclusive results of many therapeutic trials. Additionally, little significance is given to nonacid and mixed refluxates, although a significant prevalence. The association between symptoms, signs, impedance-pH studies and pepsin detection could be the most accurate way for a clear diagnosis. 'Reflux profiling' is also important for the administration of a personalized treatment based on diet, proton pump inhibitors, alginate, magaldrate and other second-line drugs. There are only a handful of studies focusing on the addition of alginate or magaldrate to the treatment of laryngopharyngeal reflux, although their contribution has extensively been demonstrated.

Summary: Diagnosis remains controversial despite improvement in impedance and availability of pepsin detection in daily practice. With recent studies exhibiting a significant prevalence of nonacid or mixed refluxes, the addition of alginate or magaldrate to proton pump inhibitors should be considered. Future studies are needed to assess these new therapeutic schemes in moderate and severe laryngopharyngeal reflux.

Similar articles

See all similar articles

Cited by 1 article

MeSH terms

LinkOut - more resources

Feedback